May 19, 2020 / 5:10 AM / 12 days ago

BRIEF-Noxopharm Lodges Pre-IND Submission For Clinical Trial Of Veyonda In COVID-19 Patients

May 19 (Reuters) - Noxopharm Ltd:

* LODGED PRE-INVESTIGATIONAL NEW DRUG SUBMISSION FOR CLINICAL TRIAL OF VEYONDA IN PATIENTS WITH SARS-COV-2 INFECTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below